MEIP MEI Pharma Inc Compare

duckduckgo

MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments

businesswire

MEI Pharma Announces Closing of Public Offering of Common Stock

apnews

MEI Pharma Announces Pricing of Public Offering of Common Stock

nasdaq

MEI Pharma: There’s More Upside Ahead, Says Analyst Who Made a Winning Call

duckduckgo

MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular Lymphoma

yahoo

MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors

yahoo

MEI Pharma Reports First Quarter Fiscal Year 2022 Results and Operational Highlights

biospace

MEI Pharma and Kyowa Kirin receive Orphan Drug Designation for Zandelisib for the Treatment of Follicular Lymphoma

yahoo

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635 - Yahoo Finance

yahoo

MEI Pharma Inc : Are Hedge Funds Right About This Stock? - Yahoo Finance

yahoo

MEI Pharma Appoints Tina C. Beamon, J.D., as Chief Compliance Officer

yahoo

MEI Pharma and Kyowa Kirin Announce First Patient with Marginal Zone Lymphoma Dosed in Expanded Global Phase 2 TIDAL Study Evaluating Zandelisib

yahoo

MEI Pharma to Host Investor and Analyst Video Webcast Event Following 2021 ASCO Annual Meeting

yahoo

MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2021 - Yahoo Finance

yahoo

MEI Pharma and Kyowa Kirin to Present Clinical Data from Phase 1b Study of Zandelisib in Combination with Zanubrutinib at the European Hematology Association 2021 Virtual Congress

zacks

MEI Pharma, Inc. Reports Q3 Loss, Misses Revenue Estimates

yahoo

MEI Pharma and Kyowa Kirin Announce Completion of Patient Enrollment in Follicular Lymphoma Primary Efficacy Population of Global Phase 2 TIDAL Study Intended to Support Potential Accelerated Approval Application from U.S. Food and Drug Administration

yahoo

MEI Pharma Presents Positive Preclinical Data For Cancer Drug Voruciclib

prnewswire

MEI Pharma Reports Preclinical Data Demonstrating Ability of Voruciclib to Regulate MYC and Synergize with KRAS Inhibitors in KRAS Mutant Cancers

yahoo

MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference

yahoo

MEI PHARMA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of MEI Pharma, Inc. - MEIP

yahoo

MEI PHARMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of MEI Pharma, Inc. - MEIP

zacks

MEI Pharma, Inc. Reports Q2 Loss, Tops Revenue Estimates

yahoo

MEI PHARMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of MEI Pharma, Inc. - MEIP